1. Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C. Issue 2 (2nd June 2014) Authors: Boursier, J.; Brochard, C.; Bertrais, S.; Michalak, S.; Gallois, Y.; Fouchard‐Hubert, I.; Oberti, F.; Rousselet, M.‐C.; Calès, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 2(2014) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?. Issue 7 (6th February 2017) Authors: Calès, P.; Boursier, J.; Lebigot, J.; de Ledinghen, V.; Aubé, C.; Hubert, I.; Oberti, F. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 7(2017) Page Start: 991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH. Issue 10 (25th March 2018) Authors: Boursier, J.; Anty, R.; Vonghia, L.; Moal, V.; Vanwolleghem, T.; Canivet, C. M.; Michalak, S.; Bonnafous, S.; Michielsen, P.; Oberti, F.; Iannelli, A.; Van Gaal, L.; Patouraux, S.; Blanchet, O.; Verrijken, A.; Gual, P.; Rousselet, M.‐C.; Driessen, A.; Hunault, G.; Bertrais, S. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 10(2018) Page Start: 1387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗